CLEVELAND BIOLABS INC - COM NEW (CBLI)

CUSIP: 185860202

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM NEW
Total 13F shares
399,490
Share change
-49,708
Total reported value
$240,000
Price per share
$0.60
Number of holders
7
Value change
-$42,705
Number of buys
3
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 185860202?
CUSIP 185860202 identifies CBLI - CLEVELAND BIOLABS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEVELAND BIOLABS INC - COM NEW (CBLI) as of Q4 2019

As of 31 Dec 2019, CLEVELAND BIOLABS INC - COM NEW (CBLI) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 399,490 shares. The largest 7 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, National Asset Management, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, ROYAL BANK OF CANADA, and BANK OF AMERICA CORP /DE/. This page lists 7 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.